By Daniel Akselrod · Licensed Attorney · July 2026

Intake Forms for Pain Management Clinics: Pain Assessment, Medication History, and Functional Impact Documentation

A pain management clinic operates at the intersection of complex clinical decision-making and intense regulatory scrutiny. Every new patient who walks through the door presents a diagnostic puzzle — chronic pain with overlapping mechanical, neuropathic, and psychosocial components, a medication history that may span multiple prescribers and pharmacies, and functional limitations that do not always correlate with imaging findings. The intake form is where that puzzle begins to take shape, and if it is not structured correctly, the clinician starts behind.

Pain management intake is not a variation of the standard medical intake. It demands specialized sections that no general-purpose medical form covers: detailed pain characterization using validated instruments, a granular opioid and controlled substance history with morphine milligram equivalent calculations, documentation of prior interventional procedures and their outcomes, functional impact assessment across activities of daily living, and state-mandated compliance elements like Prescription Drug Monitoring Program queries and urine drug screen protocols. A form that omits any of these forces the clinician to reconstruct the information from memory during the encounter, which means incomplete documentation, missed red flags, and regulatory exposure.

This guide covers what a pain management intake form should capture and why each section matters — not as a checklist, but as a clinical and legal framework that protects the practice, the patient, and the treatment relationship from the very first visit.

Comprehensive Pain Assessment: Characterizing the Problem Before Treating It

The centerpiece of any pain management intake is a structured pain assessment that goes well beyond asking the patient to rate their pain on a zero-to-ten scale. The numeric rating scale has its place, but used in isolation it tells the clinician almost nothing actionable. A patient who reports seven-out-of-ten pain could be describing sharp, lancinating radiculopathy from a herniated disc, a diffuse burning dysesthesia from small fiber neuropathy, or a deep, aching myofascial pain pattern that worsens with sitting. Each of those presentations points toward a different diagnostic workup and a different treatment pathway. The intake form needs to capture the dimensions that distinguish them.

Pain location should be documented with specificity. Rather than a single text field for "location of pain," the form should provide a body diagram — sometimes called a pain map or pain drawing — where the patient marks the affected areas and indicates the type of pain in each region. Body diagrams have been validated as screening tools for over four decades, and they remain one of the most efficient ways to identify pain patterns that suggest radiculopathy, referred visceral pain, central sensitization, or non-anatomic distributions that may warrant further psychosocial evaluation. A well-designed form includes anterior and posterior body outlines with instructions for the patient to shade, circle, or mark areas using different symbols for different pain qualities.

Pain quality deserves its own dedicated section. The McGill Pain Questionnaire and its short form remain standard instruments for this purpose, but even a simplified checklist that asks the patient to characterize their pain as sharp, dull, burning, throbbing, stabbing, aching, tingling, shooting, cramping, or pressure provides the clinician with useful diagnostic information. Burning and tingling suggest neuropathic components. Throbbing and aching point toward nociceptive or inflammatory origins. Shooting pain along a dermatomal distribution suggests nerve root involvement. The intake form should capture these descriptors systematically so the clinician does not have to tease them out during an already time-pressured initial evaluation.

Temporal characteristics matter as much as quality. The form should ask when the pain started, whether the onset was sudden or gradual, whether the pain is constant or intermittent, what time of day it is worst, and whether there are identifiable aggravating and relieving factors. A patient whose low back pain is worst in the morning and improves with movement has a different presentation than one whose pain worsens throughout the day with prolonged standing. Aggravating factors such as coughing, sneezing, Valsalva maneuver, specific postures, weather changes, stress, and activity levels should all be documented. Relieving factors — rest, heat, ice, position changes, specific medications, and activity modification — help the clinician understand what has already been tried and what provides even partial benefit.

Pain intensity should be captured using a validated scale appropriate to the patient population. The Numeric Rating Scale works for most adults, but the clinic should also have access to the Wong-Baker FACES scale for patients with limited English proficiency or cognitive impairment, and the Defense and Veterans Pain Rating Scale for veteran populations. Importantly, the intake form should capture both current pain intensity and pain intensity at its worst, at its best, and on average over the past week. This range tells the clinician far more than a single number. A patient whose pain ranges from three to nine has a different clinical picture than one whose pain sits steadily at six.

Medication History: Controlled Substances, Morphine Milligram Equivalents, and the Full Pharmacologic Picture

No section of the pain management intake carries more regulatory weight than the medication history, and no section is more frequently incomplete. Patients often cannot name every medication they take, do not remember dosages, and may not distinguish between medications prescribed by different providers. The intake form must be structured to capture this information with enough specificity that the clinician can calculate a current morphine milligram equivalent daily dose, identify potential drug interactions, and establish a baseline for treatment planning.

The current medication section should capture every prescription medication the patient is taking, with fields for medication name, dosage, frequency, prescribing provider, and how long the patient has been on that medication. For pain management specifically, the form should include a dedicated subsection for opioid medications that asks the patient to list each opioid separately with the exact dose and number of pills taken per day. This level of detail matters because morphine milligram equivalent calculations — required by most state opioid prescribing guidelines and recommended by the CDC — depend on knowing the specific opioid, the dose per unit, and the daily consumption. A patient taking oxycodone 10mg four times daily has a different MME than one taking oxycodone 30mg twice daily, even though the total daily milligrams of oxycodone are close. The form should be designed so that this calculation can be performed without ambiguity.

Beyond opioids, the intake should capture current use of benzodiazepines, muscle relaxants, gabapentinoids, antidepressants used for pain such as duloxetine and amitriptyline, topical analgesics, nonsteroidal anti-inflammatory drugs, and acetaminophen. The combination of opioids with benzodiazepines is a documented risk factor for respiratory depression and overdose death, and identifying concurrent use at intake is a patient safety imperative. Gabapentinoids have their own misuse profile that several states now monitor through their PDMPs. Documenting the full pharmacologic picture at intake allows the clinician to identify polypharmacy risks, redundant medications, and opportunities for rational simplification.

The medication history section should also capture past medications that the patient has tried and discontinued, along with the reason for discontinuation. Was the medication ineffective? Did it cause intolerable side effects? Was there an adverse reaction? Did the patient stop taking it due to cost? Was it discontinued by a previous provider, and if so, why? This information prevents the clinic from restarting a medication that has already failed, and it provides evidence that less risky alternatives were tried before escalating to controlled substances — a documentation requirement under virtually every state opioid prescribing guideline.

Allergy and adverse reaction documentation rounds out this section. The form should distinguish between true drug allergies, which involve an immunologic response such as anaphylaxis or angioedema, and adverse drug reactions or intolerances, which involve predictable pharmacologic side effects such as nausea, constipation, or drowsiness. This distinction matters clinically because a patient who reports an "allergy" to codeine due to nausea is not necessarily allergic to all opioids, while a patient who experienced anaphylaxis to a sulfonamide antibiotic has a genuine contraindication that must be flagged across the medical record.

Prescription Drug Monitoring Program Compliance and Controlled Substance Agreements

Every state in the United States now operates a Prescription Drug Monitoring Program, and most states require or strongly recommend that prescribers query the PDMP before initiating opioid therapy and at defined intervals thereafter. The intake form should include a section that documents the patient's acknowledgment that the PDMP will be checked and their consent to ongoing monitoring as a condition of controlled substance prescribing. This is not optional paperwork — it is a regulatory requirement in the majority of jurisdictions, and failure to document it creates audit exposure.

The controlled substance agreement, sometimes called a pain management contract or opioid treatment agreement, should be referenced or incorporated into the intake workflow. While the agreement itself is typically a separate document requiring the patient's signature, the intake form should capture the information that feeds into it: the patient's understanding that they will receive controlled substances from only one prescriber and fill them at only one pharmacy, their consent to random urine drug screening, their agreement to store medications securely and not share them, and their acknowledgment that violations of the agreement may result in modification or termination of opioid therapy. Documenting these expectations at intake, before the first prescription is written, establishes the framework for the treatment relationship and provides the clinic with documented evidence that the patient was informed of the rules from the outset.

Urine drug screen protocols should also be addressed at intake. Most pain management practices conduct a baseline urine drug screen at or before the initial visit, and the intake form should include the patient's consent for this testing along with a section for documenting the results. The baseline UDS serves multiple purposes: it confirms that the patient is taking the medications they report, identifies the presence of unreported substances including illicit drugs and non-prescribed controlled substances, and establishes a reference point for future testing. State regulations vary on the frequency of subsequent testing, but the intake form should document that the testing protocol was explained and consented to during the initial encounter.

Prior Interventional Procedures and Diagnostic Workup

Pain management patients rarely present as blank slates. Most have been through months or years of treatment before arriving at a specialist clinic, and the intake form needs to capture that history in enough detail to avoid repeating diagnostics that have already been performed and to understand which interventional approaches have already been tried and with what results.

The procedural history section should ask about prior epidural steroid injections, including the spinal level, approach (interlaminar versus transforaminal), number of injections, date of the most recent injection, and degree and duration of relief obtained. The same level of detail should be captured for facet joint injections, medial branch blocks, radiofrequency ablation, sacroiliac joint injections, trigger point injections, and peripheral nerve blocks. For patients who have undergone more advanced interventions, the form should ask about spinal cord stimulator trials and permanent implants, intrathecal drug delivery systems, and surgical procedures including laminectomy, discectomy, fusion, and joint replacement. Each procedure entry should include the date, the performing provider or facility, and the patient's assessment of the outcome.

This procedural history directly shapes the treatment plan. A patient who achieved significant but temporary relief from a medial branch block is a candidate for radiofrequency ablation of the same levels. A patient who had a spinal cord stimulator trial that failed to produce fifty percent pain reduction is generally not a candidate for permanent implantation. A patient who has already received the maximum recommended number of epidural steroid injections in a twelve-month period cannot receive more, regardless of how much relief they provided. Without this information documented at intake, the clinician risks proposing interventions that have already been tried, duplicating diagnostic procedures, or exceeding frequency limits established by evidence-based guidelines and payer policies.

The diagnostic workup section should capture prior imaging studies — X-rays, MRI, CT scans, bone scans, and EMG/nerve conduction studies — along with the body region imaged, the date, the facility, and the key findings if the patient can recall or provide them. Many patients arrive with imaging reports or CDs, and the intake form should prompt them to bring those records. Documenting what imaging has already been done prevents unnecessary repeat studies, which cost the patient money, expose them to additional radiation in the case of CT and X-ray, and delay the start of treatment while the clinic waits for results that already exist somewhere in the healthcare system.

Functional Impact Assessment: Pain in the Context of Daily Life

Pain intensity scores alone do not capture the clinical picture. Two patients can report identical pain levels and have vastly different functional capacities. A construction worker with chronic low back pain rated at six-out-of-ten who can no longer lift, bend, or stand for more than twenty minutes has a different treatment imperative than a retired office worker with the same pain rating who can still walk, cook, and manage self-care independently. The intake form must assess how pain affects the patient's ability to function in their actual daily life.

Activities of daily living should be assessed systematically. The form should ask about the patient's ability to dress, bathe, prepare meals, manage household tasks, drive, and perform personal hygiene — basic ADLs that establish whether the patient can live independently. Beyond basic ADLs, the form should assess instrumental activities such as shopping, managing finances, using transportation, and maintaining social relationships. Validated instruments like the Oswestry Disability Index for low back pain and the Neck Disability Index for cervical conditions provide standardized functional scoring, but even a simplified functional assessment section that asks the patient to rate their ability to perform specific activities on a five-point scale from "no difficulty" to "unable to perform" gives the clinician a baseline for tracking treatment outcomes over time.

Work status deserves particular attention. The form should capture whether the patient is currently employed, the nature of their work and its physical demands, whether they are working full duty or modified duty, whether they are on disability leave, and how long they have been out of work. Work status is relevant not only for treatment planning — a patient who needs to return to heavy manual labor has different rehabilitation goals than one who performs sedentary desk work — but also for understanding the psychosocial dimensions of the patient's pain experience. Prolonged absence from work is one of the strongest predictors of failure to return to work regardless of the underlying pain condition, and identifying patients who have been out of work for extended periods allows the clinic to incorporate vocational rehabilitation and return-to-work planning into the treatment strategy.

Sleep quality, mood, and psychological screening round out the functional assessment. Chronic pain and sleep disturbance have a bidirectional relationship — pain disrupts sleep, and poor sleep amplifies pain perception. The intake form should ask about sleep duration, sleep quality, whether pain wakes the patient at night, and current use of sleep medications. Mood screening should include at least a brief validated instrument such as the PHQ-2 or PHQ-9 for depression and the GAD-2 or GAD-7 for anxiety. Depression and anxiety are not comorbidities that happen to coexist with chronic pain — they are integral components of the chronic pain experience that, left untreated, undermine every other intervention the clinic offers. Identifying them at intake ensures they are addressed as part of a multimodal treatment plan rather than discovered months later when the patient is not responding to interventional procedures that were never going to be sufficient on their own.

Substance Use Screening and Risk Stratification

Substance use screening is a clinical necessity in pain management, not a judgment. Patients with active substance use disorders are at elevated risk for opioid misuse, overdose, and adverse outcomes from sedating medications. Patients in recovery from substance use disorders may have strong preferences about which medications are acceptable to them and which they wish to avoid. In either case, the intake form needs to capture this information so the clinician can tailor the treatment plan accordingly.

The form should ask about current and past use of alcohol, tobacco, cannabis, illicit drugs, and non-prescribed controlled substances. For alcohol, quantifying consumption matters — the number of drinks per week, whether there has been a period of heavy or problematic use, and whether the patient has ever been treated for alcohol use disorder. Tobacco use is clinically relevant because smoking is associated with poorer outcomes from spinal surgery, delayed wound healing, and reduced efficacy of certain interventional procedures. Cannabis use is increasingly common among pain patients and should be documented regardless of legal status in the jurisdiction, as it interacts with opioids and other CNS depressants and may affect the interpretation of urine drug screen results.

Validated opioid risk assessment tools should be incorporated into the intake workflow. The Opioid Risk Tool, the Screener and Opioid Assessment for Patients with Pain (SOAPP), and the revised SOAPP-R are widely used instruments that stratify patients into low, moderate, and high risk categories for opioid misuse. These tools are not diagnostic — they are screening instruments that guide the level of monitoring and the frequency of urine drug screens and PDMP checks. A high-risk score does not preclude opioid therapy, but it does indicate that the patient requires closer monitoring, more frequent follow-up, and potentially a referral for concurrent substance use disorder treatment. Documenting the risk score at intake creates a defensible clinical rationale for the monitoring intensity the clinic applies to that patient.

Workers Compensation, Litigation Status, and Referral Source Documentation

Pain management clinics see a substantial volume of patients whose treatment is complicated by workers compensation claims, personal injury litigation, motor vehicle accident claims, and disability determinations. These cases carry documentation requirements that differ from standard clinical encounters, and the intake form must identify them upfront so the clinic's administrative and clinical staff can handle them correctly from the start.

The form should ask whether the patient's pain condition is related to a workplace injury, a motor vehicle accident, or any other incident that is the subject of a legal claim. If so, the form should capture the date of injury, the workers compensation carrier or auto insurance carrier, the claim number, the adjuster's name and contact information, and whether the patient has an attorney. This information is necessary for billing — workers compensation and auto insurance are billed differently than commercial health insurance and Medicare — and for ensuring that the clinic sends records and reports to the correct parties.

Litigation status matters clinically as well as administratively. Research consistently shows that patients involved in active litigation or compensation claims report higher pain levels, demonstrate greater functional impairment, and respond less robustly to treatment than patients with the same diagnoses who are not in litigation. This is not evidence of malingering — it reflects the complex psychosocial dynamics of the compensation and legal systems and their effect on pain perception and recovery. Documenting litigation status at intake allows the clinician to interpret treatment response in context and to address the patient's expectations about the relationship between their legal case and their clinical care.

Referral source documentation serves both clinical and business purposes. The form should capture who referred the patient to the pain management clinic — a primary care physician, an orthopedic surgeon, a neurologist, a chiropractor, an attorney, or self-referral. For physician referrals, capturing the referring provider's name, practice, and contact information facilitates coordination of care, co-management of medications, and communication about the treatment plan. For attorney referrals, the documentation establishes the context of the referral and allows the clinic to manage the additional record-keeping requirements that legal cases entail.

Multimodal Treatment History: What Has Already Been Tried

Pain management best practices emphasize multimodal therapy — combining pharmacologic, interventional, rehabilitative, and psychological approaches rather than relying on any single modality. The intake form should capture the patient's history with each of these domains so the clinician understands what the patient has already tried, what worked, what did not, and what the patient is willing to try going forward.

Physical therapy is typically the first non-pharmacologic intervention attempted, and the intake should ask whether the patient has participated in physical therapy, how many sessions they completed, what type of therapy was provided (manual therapy, therapeutic exercise, aquatic therapy, traction, electrical stimulation), and whether it helped. Many patients report that physical therapy "didn't work," but further inquiry reveals that they attended only three sessions out of a prescribed twelve, or that the therapy focused on passive modalities rather than active exercise, or that they were referred to a general physical therapist rather than one specializing in the patient's condition. This detail helps the clinician determine whether a re-referral to physical therapy with a different approach might be warranted.

Chiropractic care, acupuncture, massage therapy, and other complementary approaches should also be documented. These modalities are increasingly integrated into evidence-based pain management programs, and knowing whether the patient has tried them — and the outcome — helps the clinician build a comprehensive treatment plan. Some patients have strong preferences for or against specific modalities, and capturing those preferences at intake avoids recommending treatments the patient has already rejected or has had negative experiences with.

Psychological and behavioral health interventions are a critical but often under-documented component of the multimodal treatment history. The form should ask whether the patient has participated in cognitive behavioral therapy for chronic pain, pain psychology, biofeedback, mindfulness-based stress reduction, or other psychological interventions. Patients who have not yet engaged with the psychological dimensions of their pain often benefit significantly from these approaches, and identifying them at intake allows the clinic to make the referral early in the treatment relationship rather than offering it as a last resort after interventional procedures have been exhausted.

Beyond PDMP and controlled substance agreements, the broader regulatory landscape varies by state and shapes how the intake form must be designed. Clinics that treat patients across state lines — increasingly common with telemedicine — need to ensure that their intake forms meet the most stringent applicable standard. Most states require documentation of a PDMP query before initiating opioid therapy and at regular intervals during ongoing treatment. The intake form should include a section where the clinician documents that the PDMP was checked, the date of the query, and any findings of concern. Some states require that the PDMP report itself be printed and placed in the chart. Others require documentation of specific findings, such as the number of prescribers and pharmacies appearing in the PDMP, any overlapping controlled substance prescriptions, and any evidence of doctor shopping or pharmacy shopping. Building these fields into the intake form ensures that the documentation happens at the point of care rather than being reconstructed after the fact during an audit.

Informed consent for opioid therapy is another state-specific requirement that should be addressed at or near intake. Several states require a separate informed consent document that details the risks of opioid therapy, including the risks of addiction, physical dependence, respiratory depression, overdose, and death. The intake form should reference whether this consent was obtained and where the signed document is filed. Some states also require specific counseling about naloxone availability, safe storage and disposal of opioids, and the risk of concurrent use with benzodiazepines and alcohol. Documenting that this counseling occurred protects the practice in the event of an adverse outcome and demonstrates compliance with prescribing guidelines.

Treatment plan documentation standards in pain management require that the initial treatment plan address the five As: analgesia, activities, adverse effects, aberrant behaviors, and affect. While the treatment plan itself is developed after the clinical encounter, the intake form gathers the raw material for each of these domains. The pain assessment informs the analgesia plan. The functional assessment establishes the activity baseline. The medication history identifies prior adverse effects. The substance use screening and risk stratification tools address aberrant behavior risk. The mood screening captures affect. A well-designed intake form does not just collect data — it organizes the data in a way that maps directly onto the required elements of the treatment plan, reducing the clinician's documentation burden and ensuring that nothing is missed.

Pain management clinics that invest in a thorough, well-structured intake process reap the benefits across every dimension of practice management. Clinicians spend less time gathering history during the encounter and more time examining the patient and discussing the treatment plan. Documentation meets regulatory requirements without requiring after-the-fact chart completion. Risk stratification happens before the first prescription is written, not after a crisis. And the patient experiences a clinic that takes their pain seriously enough to understand it comprehensively before proposing a single intervention. That is not just good medicine — it is the standard of care, and the intake form is where it begins.

Streamline Your Pain Management Intake Process

Templateez offers professionally designed, fillable PDF intake forms and client questionnaires built for healthcare practices. Each form captures the clinical, regulatory, and administrative information your specialty requires — ready to download, fill, and use immediately.

Browse All Forms View Bundles

Not ready to buy? Download our free Universal Intake Form — a fillable PDF you can use today, no purchase needed.